2011—2015年甘肃省敦煌市恶性肿瘤发病分析

Incidence of Cancer in Dunhuang City from 2011 to 2015

[目的]分析甘肃省敦煌市2011—2015年恶性肿瘤发病情况,为政府制定肿瘤防控措施提供科学依据。[方法]利用2011—2015年敦煌市肿瘤登记报告资料,计算5年恶性肿瘤粗发病率、死亡率、中标率、世标率、累积率和截缩率等指标。[结果]敦煌市2011—2015年恶性肿瘤新发病例1760例(男性919例,女性841例),性别比为1.09∶1;各年度恶性肿瘤发病率趋势平稳,男性发病率、中标率、世标率、累积率各年度均高于女性,5年截缩率(35~64岁)男性与女性相比,呈先低后高的趋势。2011—2015年敦煌市恶性肿瘤发病率随年龄增长而上升,在75~79岁年龄组达到高峰,之后逐渐下降。发病前5位分别是女性乳腺癌、胃癌、肺癌、结直肠癌和肝癌,占全部恶性肿瘤的55.63%。[结论]女性乳腺癌、胃癌、肺癌、结直肠癌、肝癌是敦煌市高发癌种,也是防治工作的重点;女性乳腺癌、宫颈癌、子宫内膜癌均进入全人群发病顺位前10位,应是重点关注的癌种。

[Purpose]To analyze the incidence of cancer in Dunhuang City,Gansu Province from 2011 to 2015,and to provide scientific basis for the government to formulate prevention and control measures.[Methods]Tumor registration report data of Dunhuang City from 2011 to 2015 was used,the crude 5-years malignant tumor morbidity and mortality,the Chinese standard rate,the world standard rate,the cumulative rate and the truncated rate were calculated.[Results]There were 1760 new malignant tumor cases(919 males and 841 females)in Dunhuang City from 2011 to2015,with a gender ratio of 1.09∶1.The incidence rate of malignant tumors in each year was stable.The incidence rate,the Chinese standard rate,the world standard rate and the cumulative rate in male were higher than those in female in each year.But the truncated age incidence rate of the age group of 35~64 years was first lower then higher than when compare male to female.The incidence of malignant tumors increased with age and reached a peak at the age group of 75~79 years,and then decreased gradually.The top five common malignant tumors were female breast cancer,stomach cancer,lung cancer,colorectal cancer and liver cancer,accounting for 55.63%of all malignant tumors.[Conclusion]Female breast cancer,stomach cancer,lung cancer,colorectal cancer and liver cancer are the high incidence cancers in Dunhuang City,and will be the focus of future prevention and treatment work.Female breast cancer,cervical cancer,endometrium cancer have all entered the top 10 in the incidence sequence of the whole population,so focus on the female-related cancers should be strengthened.